Malignant Brain Tumors
88,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

This text addresses all aspects of patient evaluation and care. This includes new findings in imaging that provide a better understanding of the extent of the lesion as well as its relationship with critical neuroanatomic function. The evolution of intraoperative imaging, functional brain mapping,and technology to identify tumor from brain is covered. This has significantly improved the ability of surgeons to more safely and aggressively remove tumors.More importantly, a better understanding of tumor biology and genomics has created an opportunity to significantly revise tumor classification…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
This text addresses all aspects of patient evaluation and care. This includes new findings in imaging that provide a better understanding of the extent of the lesion as well as its relationship with critical neuroanatomic function. The evolution of intraoperative imaging, functional brain mapping,and technology to identify tumor from brain is covered. This has significantly improved the ability of surgeons to more safely and aggressively remove tumors.More importantly, a better understanding of tumor biology and genomics has created an opportunity to significantly revise tumor classification and better select optimal therapy for individual patients. The text covers novel and innovative treatment options including immunotherapy, tumor vaccines, antiangiogenic agents,and personalized cancer treatment. In addition, novel agent delivery techniques are covered to offer the potential for increasing the effectiveness of treatment by delivering active agents directly where they areneeded most.
Malignant Brain Tumors: State-of-the-Art Treatment provides a comprehensive overview of treatment for malignant gliomas, and will prove useful by updating physicians on new therapeutic paradigms and what is on the horizon for the near future. This text will be informative for surgeons, oncologists, neurologists, residents and students who treat these patients,as well as those who are training for a career in managing patients with these challenging tumors.
Autorenporträt
Joseph M Piepmeier, MDNixdorff-German Professor of NeurosurgeryDepartment of NeurosurgeryYale University School of MedicineNew Haven, ConnecticutUSA Jennifer Moliterno Gunel, MDAssistant Professor, Department of NeurosurgerySection of Neurosurgical OncologyYale University School of MedicineNew Haven, ConnecticutUSA Joachim M. Baehring, MD, DSc.Department of Neurology and NeurosurgeryYale University School of MedicineNew Haven, ConnecticutUSA
Rezensionen
"This textbook analyzes the dismal prognosis and very limited efficacy for single or multi agent therapy of Glioblastomas GBMs. ... I recommend this book to neurosurgeons and oncologists" (Joseph Grenier, Amazon.de, May, 2018)

"This succinct book is designed as a comprehensive, yet concise update on the contemporary treatment of gliomas. ... The audience includes neurosurgeons, neurologists, oncologists, and all practitioners with routine exposure to gliomas. ... This is a satisfactory update on the contemporary biology and treatment for neuro-oncology's enduring foe: gliomas. ... The book provides a succinct, effective research update for clinicians wishing to familiarize themselves with advances in the field over the last decade." (Darian Ross Esfahani, Doody's Book Reviews, April, 2017)